Sofinnova Investments, Inc. Intercept Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$77.77 - $120.68 $3.49 Million - $5.42 Million	-44,918 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $877,343 - $1.15 Million	-9,554 Reduced 17.54%	44,918 $5.02 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $4.67 Million - $6.89 Million	54,472 New	54,472 $5.49 Million
Q3 2018 Nov 15, 2018	SELL	$88.49 - $127.55 $9.45 Million - $13.6 Million	-106,817 Closed	0 $0
Q2 2018 Nov 15, 2018	BUY	$60.0 - $85.67 $5.75 Million - $8.21 Million	95,812 Added 870.62%	106,817 $8.96 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $660,300 - $942,798	11,005 New	11,005 $923,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.